Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis;Traitement du syndrome d'activation macrophagique sévère associé à une leishmaniose viscérale

Archives de Pediatrie

Volumn 17, Issue 11, 2010, Pages 1566-1570

  Bouguila, J ^a   Chabchoub, I ^a   Moncef, Y ^a   Mlika, A ^a   Saghrouni, F ^a   Boughamoura, L ^a   Essoussi, A S ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CORTICOSTEROID; DEXAMETHASONE SODIUM PHOSPHATE; ETOPOSIDE; FOSFOMYCIN; FOSFOMYCINE; HYDROCORTISONE SODIUM SUCCINATE; IMMUNOGLOBULIN; MEGLUMINE ANTIMONATE; UNCLASSIFIED DRUG; VANCOMYCIN; VANCOMYCINE; VEINOGLOBULINES;

ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; FATALITY; FEVER; FOLLOW UP; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; HYPOXEMIA; IMMUNOTHERAPY; KIDNEY FAILURE; LEISHMANIA; LIVER FAILURE; METABOLIC ACIDOSIS; NEUTROPENIA; PANCYTOPENIA; PETECHIA; PRESCHOOL CHILD; PURPURA; RESPIRATORY DISTRESS; SEPTICEMIA; SEROLOGY; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIPROTOZOAL AGENTS; DRUG THERAPY, COMBINATION; ETOPOSIDE; FATAL OUTCOME; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS; INFANT; LEISHMANIA; LEISHMANIASIS, VISCERAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; TREATMENT OUTCOME;

EID: 78049450962     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2010.08.018     Document Type: Article

References (12)

1. Larroche C., Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004, 3:69-75.
2. Pradalier A., Teillet F., Molitor J.L., et al. Syndrome d'activation macrophagique (syndrome d'hémophagocytose). Pathol Biol 2004, 52:407-414.
3. Créput C., Galicier L., Oksenhendler E., et al. Syndrome d'activation lymphohistiocytaire: revue de littérature, implications en réanimation. Reanimation 2005, 14:604-613.
4. Karras A., Hermine O. Syndrome d'activation macrophagique. Rev Med Interne 2002, 23:768-778.
5. Henter J.I., Horne A.C., Arico M., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48:124-131.
6. Lakhdher Idrissi M., El Ouardi M., Atmani S., et al. La leishmaniose viscérale infantile: à propos de 209 cas. J Pediatr Pueric 2007, 20:136-141.
7. Brastianos P.K., Swanson J.W., Torbenson M., et al. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis 2006, 6:447-454.
8. Rouphael N.G., Talati N.J., Vaughan C., et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007, 7:814-822.
9. Kilani B., Ammari L., Kanoun F., et al. Hemophagocytic syndrome associated with visceral leishmaniasis. Int J Infect Dis 2006, 10:85-86.
10. Rajagopala S., Dutta U., Poorna Chandra K.S., et al. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis - case report and systematic review. J Infect 2008, 56:381-388.
11. Janka G.E. Hemophagocytic syndromes. Blood Rev 2007, 21:245-253.
12. Stéphan J.L., Galambrun C. Syndrome d'activation lymphohistiocytaire chez l'enfant. Arch Pediatr 2000, 7:278-286.